{"url_path":"/sec/coll/13dg/2026-05-12/000110465926059548","section_key":"body","section_title":"SCHEDULE 13G body","topic":"sec","document":{"doc_type":"SCHEDULE 13G","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1267565/0001104659-26-059548-index.html","accession_number":"0001104659-26-059548","cik":"0001267565","ticker":"COLL","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1267565/0001104659-26-059548-index.html","primary_entity_key":"0001267565","primary_entity_name":"COLLEGIUM PHARMACEUTICAL, INC"},"word_count":188,"has_tables":true,"body_markdown":"EX-99.1\n2\ntm2614409d1_ex-1.htm\nEXHIBIT 1\n\nEXHIBIT I\n\nJOINT FILING AGREEMENT\n\nThis will confirm the agreement by and among the undersigned\nthat the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership\nby the undersigned of the Common Stock, par value $0.001 per share, of Collegium Pharmaceutical, Inc. will be filed on behalf of each\nof the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement\nmay be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one\nand the same instrument.\n\nDated: May 11, 2026\n\nINTEGRATED CORE STRATEGIES (US) LLC\n\nBy:\nIntegrated Holding Group LP,\n\nits Managing Member\n\nBy:\nMillennium Management LLC,\n\nits General Partner\n\nBy:\n/s/ Gil Raviv\n\nName: Gil Raviv\n\nTitle: Global General Counsel\n\nMILLENNIUM MANAGEMENT LLC\n\nBy:\n/s/ Gil Raviv\n\nName: Gil Raviv\n\nTitle: Global General Counsel\n\nMILLENNIUM GROUP MANAGEMENT LLC\n\nBy:\n/s/ Gil Raviv\n\nName: Gil Raviv\n\nTitle: Global General Counsel\n\n/s/ Israel A. Englander\n\nIsrael A. Englander"}